Video: HCV Video Series: Individualised HCV
Boehringer Ingelheim (Canada) Ltd.
Canada NewsWire
Also See: Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising Phase II data (Press release November 01, 2013)
No comments:
Post a Comment